ARTICANZ - Beta (ver 0.91)
Annotated Registry of Trials in Cancer, Australia and New Zealand Ed.
- Results - catype/medical-oncology/respiratory
Home
By cancer type
By drug class
By site
Data
FAQ
About
⚠
ARTICANZ provides informational content about cancer drug trials in Australia/NZ that is updated weekly but may not be completely accurate, and should not replace medical advice from qualified healthcare professionals. The platform is intended to be useful, providing information "as is" without warranties. Non-medical users must always consult healthcare providers for all clinical decisions.
Search results
Respiratory
34
trial(s) found.
NCT07843940
Advanced
Phase 1 / Phase 2
Recruiting
A Phase Ib/II, Open-label, Safety and Tolerability Trial of Intravenous Obrixtamig in Combination With Pumitamig and Standard of Care (Carboplatin, Etoposide) in Patients With Extensive-stage Small Cell Lung Carcinoma (
1438-0035
)
bispecific PD-L1/VEGFA antibody
bispecific T-cell engager,DLL3-targeting
platinum-based antineoplastic agent
topoisomerase inhibitor
Small-cell lung cancer
NSW
2050 - Camperdown - Chris O'Brien Lifehouse
QLD
4814 - Douglas - Townsville Cancer Centre - The Townsville Hospital
NCT07778316
Advanced
Phase 3
Recruiting
A Phase 3, Open-Label, Multicenter, Randomized Study of Subcutaneous vs Intravenous Tarlatamab in Participants With Relapsed Extensive-Stage Small Cell Lung Cancer After Platinum-based First-line Chemotherapy (
DeLLphi-315
)
bispecific T-cell engager,DLL3-targeting
Small-cell lung cancer
SA
5112 - Elizabeth Vale - Lyell McEwin Hospital
NCT07713732
Advanced
Phase 1
Recruiting
An Open-Label, Multicenter, Phase 1 Trial to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors (
TLN-499-2601
)
Bcl-xL degrader
Bcl2 inhibitor
Neuroendocrine tumour
Pleural mesothelioma
Small-cell lung cancer
Synovial sarcoma
NSW
2050 - Camperdown - Chris O'Brien Lifehouse
VIC
3144 - Malvern - Cabrini Health, Cabrini Cancer Care Centre
WA
6009 - Nedlands - Linear Clinical Research
NCT07625644
Advanced
Phase 3
Recruiting
A Phase 3 Open-Label, Randomized Controlled Trial of BL-M14D1 and Atezolizumab vs. Standard-of-Care Therapy in Patients With First-Line Extensive-Stage Small Cell Lung Cancer (
BL-M14D1-LC-301
)
anti-DLL3 antibody-drug conjugate,topoisomerase inhibitor 1-payload
anti-PD-L1 monoclonal antibody
Lung cancer
Small-cell lung cancer
Small-cell neuroendocrine carcinoma
ACT
2605 - Garran - The Canberra Hospital
QLD
4215 - Southport - Tasman Oncology
SA
5042 - Bedford Park - Flinders Medical Centre
NCT07623369
Advanced
Phase 1
Recruiting
An Open-Label, Multicenter, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Preliminary Antitumor Activity of HH160 Alone or in Combination With Other Antitumor Agents in Patients With Advanced or Metastatic Solid Tumors (
HH160-101
)
trispecific PD-1/VEGFA/CTLA4 antibody
Small-cell lung cancer
NSW
2298 - Waratah - Calvary Mater Newcastle Medical Oncology
QLD
4215 - Southport - Tasman Oncology
NCT07564401
Advanced
Phase 1 / Phase 2
Recruiting
A Phase I/II Open-label Study of DJI136, a DLL3-targeted CAR-T Therapy, in Adult Patients With ES-SCLC (
CDJI136A12101
)
autologous CAR-T-cell therapy,DLL3-targeting
Small-cell lung cancer
VIC
3168 - Clayton - Monash Medical Centre
NCT07544654
Advanced
Phase 3
Recruiting
A Phase III, Multi-center, Open-label, Randomised, Controlled Trial of Intravenous Obrixtamig in Combination With Carboplatin and Etoposide vs. Carboplatin and Etoposide as First-line Therapy in DLL3-positive Patients With Unresectable Locally Advanced or Metastatic Extrapulmonary Neuroendocrine Carcinomas (
1438-0011
)
bispecific T-cell engager,DLL3-targeting
platinum-based antineoplastic agent
topoisomerase inhibitor
Lung neuroendocrine tumour
NSW
2065 - St Leonards - Northern Sydney Cancer Centre, Royal North Shore Hospital
VIC
3000 - Melbourne - Peter MacCallum Cancer Centre
SA
5042 - Bedford Park - Flinders Medical Centre
WA
6150 - Murdoch - Fiona Stanley Hospital
NZ
NZ.1023 - Grafton - Auckland City Hospital - Cancer & Blood Research
NCT07531095
Advanced
Phase 1
Recruiting
A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Tarlatamab in Combination With ZL-1310 With or Without Anti-PD-L1 in Participants With Small Cell Lung Cancer (
DeLLphi-313
)
anti-DLL3 antibody-drug conjugate
bispecific T-cell engager,DLL3-targeting
Small-cell lung cancer
VIC
3168 - Clayton - Monash Medical Centre
NCT07476287
Advanced
Phase 2
Recruiting
A PHASE 2 INTERVENTIONAL STUDY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY IN PARTICIPANTS WITH PREVIOUSLY UNTREATED TRANSFORMED SMALL CELL LUNG CANCER (
C6461014
)
bispecific PD-1/VEGF antibody
Lung cancer
Small-cell lung cancer
Small-cell neuroendocrine carcinoma
NSW
2145 - Westmead - The Crown Princess Mary Cancer Centre - Westmead Hospital
VIC
3084 - Heidelberg - Warringal Private Hospital
SA
5112 - Elizabeth Vale - Lyell McEwin Hospital
NCT07472517
Advanced
Phase 3
Recruiting
DAREON ® -Lung-1: A Phase III Multi-center, Open-label, Randomised Trial of Intravenous Obrixtamig in Combination With Atezolizumab, Carboplatin, and Etoposide vs. Atezolizumab, Carboplatin, and Etoposide as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer (
1438-0012
)
anti-PD-L1 monoclonal antibody
bispecific T-cell engager,DLL3-targeting
platinum-based antineoplastic agent
topoisomerase inhibitor
Small-cell lung cancer
NSW
2031 - Randwick - Prince of Wales Hospital
VIC
3350 - Ballarat - Grampians Health Service's Ballarat Base Hospital
SA
5000 - Adelaide - Royal Adelaide Hospital - Adelaide Cancer Centre
NZ
NZ.1023 - Grafton - Auckland City Hospital - Cancer & Blood Research
NZ.3210 - Hamilton - Waikato Hospital
NCT07226999
Advanced
Phase 2 / Phase 3
Recruiting
A GLOBAL PHASE 2/3 INTERVENTIONAL STUDY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY IN PARTICIPANTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER (
C6461004
)
bispecific PD-1/VEGF antibody
Small-cell lung cancer
NSW
2145 - Westmead - The Crown Princess Mary Cancer Centre - Westmead Hospital
QLD
4575 - Birtinya - Sunshine Coast University Hospital
NCT07174583
Advanced
Phase 1 / Phase 2
Recruiting
A Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of IDE849 in Patients With DLL3-Expressing Tumors Including Small Cell Lung Cancer (
IDE849-001
)
anti-DLL3 antibody-drug conjugate
Small-cell lung cancer
VIC
3144 - Malvern - Cabrini Health, Cabrini Cancer Care Centre
NCT07099898
Advanced
Phase 3
Recruiting
Phase 3, Multicenter, Randomized, Open-label Clinical Study of GSK5764227, a B7-H3 Antibody Drug Conjugate (ADC), Compared With Topotecan in Participants With Relapsed Small Cell Lung Cancer (SCLC)
anti-B7H3 antibody-drug conjugate,topoisomerase inhibitor 1-payload
topoisomerase inhibitor
Small-cell lung cancer
NSW
2065 - St Leonards - Northern Sydney Cancer Centre, Royal North Shore Hospital
2148 - Blacktown - Blacktown Hospital, Blacktown Cancer and Haematology Centre
VIC
3000 - Melbourne - Peter MacCallum Cancer Centre
WA
6009 - Nedlands - Linear Clinical Research (WITHDRAWN)
NCT06926075
Advanced
Phase 1 / Phase 2
Recruiting
An Adaptive Phase I/II Study of KESONOTIDEâ„¢, a Novel hGIIA-vimentin Inhibitor, in Participants With Solid Tumours (
ADVICE
)
hGIIA-vimentin inhibitor
Breast cancer
Glioblastoma
Lung cancer
Ovarian cancer
Pancreatic cancer
Prostate cancer
Skin cancer
NSW
2170 - Liverpool - Liverpool Hospital
2217 - Kogarah - St George Private Hospital
2228 - Miranda - Southside Cancer Care Centre
NCT06910657
Advanced
Phase 1
Recruiting
A First-in-human, Phase I, Multi-center, Open-label, Dose-escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Evidence of Antitumor Activity of IDOV-Immune in Adult Participants With Advanced Solid Tumors (
VM-002-101
)
oncolytic virus,undisclosed mechanism
Bladder cancer
Breast cancer
Cancer
Cervical cancer
Clear cell renal cell carcinoma
Colorectal cancer
Gastric cancer
Head and neck cancer
Hepatocellular carcinoma
Lung cancer
Melanoma
Oesophageal cancer
Ovarian cancer
Pancreatic cancer
Prostate cancer
Sarcoma
NSW
2145 - Westmead - The Crown Princess Mary Cancer Centre - Westmead Hospital
VIC
3004 - Melbourne, Southbank - Alfred Health
NCT06892548
Advanced
Phase 1 / Phase 2
Recruiting
A Phase Ib/II, Multi-site, Open-label, Two-part Trial to Evaluate the Efficacy, Safety, Pharmacokinetics, and Recommended Combination Dose of BNT324 With BNT327 in Participants With Advanced Lung Cancer (
BNT324-01
)
anti-B7H3 antibody-drug conjugate
anti-B7H3 antibody-drug conjugate,topoisomerase inhibitor 1-payload
bispecific PD-L1/VEGFA antibody
Lung cancer
NSW
2050 - Camperdown - Chris O'Brien Lifehouse
VIC
3021 - St Albans - Western Health - Sunshine Hospital
3220 - Geelong - Andrew Love Cancer Centre, University Hospital Geelong
3550 - Bendigo - Bendigo Health - Bendigo Cancer Centre
SA
5042 - Bedford Park - Flinders Medical Centre
WA
6008 - Subiaco - Bendat Family Comprehensive Cancer Centre - St John of God Subiaco Hospital
NCT06801834
Advanced
Phase 3
Recruiting
A Global, Multicenter, Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Standard of Care (SOC) in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer (ES-SCLC) (
EVOKE-SCLC-04
)
anti-Trop2 antibody-drug conjugate
Small-cell lung cancer
NSW
2500 - Wollongong - Cancer Care Wollongong
VIC
3065 - Fitzroy - St Vincent's Hospital Melbourne
QLD
4006 - Herston - The Royal Brisbane and Women's Hospital Cancer Centre
4215 - Southport - Gold Coast University Hospital
SA
5000 - Adelaide - Cancer Research SA
WA
6009 - Nedlands - Sir Charles Gairdner Hospital - WA Cancer Centre
NCT06780137
Advanced
Phase 1 / Phase 2
Recruiting
A Phase 1b/2 Open-Label Clinical Study to Evaluate the Safety and Efficacy of MK-6070 and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (
6070-002
)
anti-B7H3 antibody-drug conjugate,topoisomerase inhibitor 1-payload
trispecific T-cell engager,DLL3-targeting
Small-cell lung cancer
VIC
3168 - Clayton - Monash Medical Centre
QLD
4102 - Woolloongabba - Princess Alexandra Hospital
NCT06726148
Advanced
Phase 1 / Phase 2
Recruiting
An Open-label, Multi-center, Phase I/II Study of ECI830 as a Single Agent and in Combination With Ribociclib and Endocrine Therapy in Patients With Advanced Hormone Receptor Positive, HER2-negative Breast Cancer and Advanced Solid Tumors (
CECI830A12101
)
CDK2 inhibitor
CDK4/6 inhibitor
Breast cancer
Small-cell lung cancer
Solid tumour
VIC
3004 - Melbourne, Southbank - Alfred Health
3168 - Clayton - Monash Medical Centre
NCT06712355
Advanced
Phase 3
Recruiting
A Phase III, Multisite, Double-blinded Randomized Trial of BNT327 in Combination With Chemotherapy (Etoposide/Carboplatin) Compared to Atezolizumab in Combination With Chemotherapy (Etoposide/Carboplatin) in Participants With First-line Extensive-stage Small-cell Lung Cancer (
BNT327-03
)
anti-PD-L1 monoclonal antibody
bispecific PD-L1/VEGFA antibody
platinum-based antineoplastic agent
topoisomerase inhibitor
Small-cell lung cancer
NSW
2065 - St Leonards - Northern Sydney Cancer Centre, Royal North Shore Hospital
2170 - Liverpool - Liverpool Hospital
2298 - Waratah - Calvary Mater Newcastle Medical Oncology
2500 - Wollongong - Cancer Care Wollongong
VIC
3021 - St Albans - Western Health - Sunshine Hospital
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre
3199 - Frankston - Peninsula Health Frankston Hospital
QLD
4870 - Cairns - Cairns Base Hospital
SA
5011 - Woodville South - The Queen Elizabeth Hospital
5037 - Kurralta Park - Icon Cancer Centre Adelaide
WA
6009 - Nedlands - Sir Charles Gairdner Hospital - WA Cancer Centre
NCT06646276
Advanced
Phase 3
Recruiting
A Randomized, Double Blind, Multicenter Phase 3 Trial of BMS-986489 (Atigotatug+Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide vs Atezolizumab in Combination With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS). (
CA245-0001
)
anti-PD-1 monoclonal antibody
anti-PD-L1 monoclonal antibody
anti-fucosyl-GM1 monoclonal antibody
platinum-based antineoplastic agent
topoisomerase inhibitor
Small-cell lung cancer
NSW
2560 - Campbelltown - Macarthur Cancer Therapy Centre - Campbelltown Hospital
2747 - Kingswood - Nepean Hospital - Nepean Cancer Care Centre
VIC
3350 - Ballarat - Grampians Health Service's Ballarat Base Hospital (COMPLETED)
QLD
4120 - Greenslopes - Greenslopes Private Hospital
WA
6150 - Murdoch - Fiona Stanley Hospital
NCT06613009
Advanced
Phase 1
Recruiting
A Phase 1 Multicenter, Open-label Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer (
CIBI3009A101
)
anti-DLL3 antibody-drug conjugate
Small-cell lung cancer
NSW
2145 - Westmead - The Crown Princess Mary Cancer Centre - Westmead Hospital
2500 - Wollongong - Wollongong Hospital
VIC
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre
NCT06598306
Advanced
Phase 1
Recruiting
A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-Tumor Activity of Subcutaneous Tarlatamab in Subjects With Extensive Stage Small Cell Lung Cancer (
DeLLphi-308
)
bispecific T-cell engager,DLL3-targeting
Small-cell lung cancer
NSW
2050 - Camperdown - Chris O'Brien Lifehouse
2298 - Waratah - Calvary Mater Newcastle Medical Oncology
VIC
3004 - Melbourne, Southbank - Alfred Health
NCT06203210
Advanced
Phase 3
Recruiting
A Phase 3, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd), a B7-H3 Antibody Drug Conjugate (ADC), Versus Treatment of Physician's Choice (TPC) in Subjects With Relapsed Small Cell Lung Cancer (SCLC) (
IDeate-Lung02
)
anti-B7H3 antibody-drug conjugate,topoisomerase inhibitor 1-payload
Small-cell lung cancer
NSW
2050 - Camperdown - Chris O'Brien Lifehouse
VIC
3021 - St Albans - Western Health - Sunshine Hospital
3350 - Ballarat - Grampians Health Service's Ballarat Base Hospital
QLD
4102 - Woolloongabba - Princess Alexandra Hospital
4814 - Douglas - Townsville Cancer Centre - The Townsville Hospital
SA
5042 - Bedford Park - Flinders Medical Centre
WA
6008 - Subiaco - Bendat Family Comprehensive Cancer Centre - St John of God Subiaco Hospital
NCT06127654
Radonc
Phase 3
Recruiting
VITaL
: A Randomised Controlled Trial Investigating Ventilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation Therapy
radiotherapy
Lung cancer
NSW
2170 - Liverpool - Liverpool Hospital
NCT04676828
Radonc
NA
Recruiting
Functional Lung Avoidance SPECT-guided (
ASPECT
) Radiation Therapy for Lung Cancer Patients: Phase II Randomised Clinical Trial
radiotherapy
Lung cancer
NSW
2145 - Westmead - The Crown Princess Mary Cancer Centre - Westmead Hospital
NCT04086082
Radonc
NA
Recruiting
MAGIK
: Using Implanted Markers to Determine the Feasibility of Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging: A Phase I Interventional Study of Lung Cancer Radiotherapy
radiotherapy
Lung cancer
VIC
3004 - Melbourne, Southbank - Alfred Health
ACTRN12626001110370
Advanced
Not Applicable
Not yet recruiting
Intranodal forceps and cryobiopsy for acquiring tissue from mediastinal lymph nodes during endobronchial ultrasound transbronchial nodal biopsy: A Randomised Controlled Study
Lung cancer
Lymphoma
ACTRN12626000966392
Radonc
Not Applicable
Not yet recruiting
DAY-TRIPPER
- Feasibility of rapid-access single-fraction stereotactic ablative radiotherapy for cancer patients in regional and rural NSW
radiotherapy
Cancer
Small-cell lung cancer
NSW
2250 - Gosford - Central Coast Cancer Centre, Gosford Hospital
2298 - Waratah - Calvary Mater Newcastle Medical Oncology
2340 - Tamworth - Tamworth Hospital-North West Cancer Centre
ACTRN12625000697482
Advanced
Phase 2
Recruiting
A parallel-group, 2-arm, Phase 2, multisite, stratified, double-blind, randomised, study to investigate the safety and effectiveness of doxycycline or placebo in conjunction with standard of care in adults with metastatic adenocarcinoma of the lung undergoing targeted anti-cancer therapy. (
DULCE
)
placebo
tetracycline antibiotic
Lung cancer
NT
0870 - Alice Springs, Alice Springs Hospital
NSW
2010 - Darlinghurst - St Vincent's Hospital Sydney - The Kinghorn Cancer Centre
2050 - Camperdown - Chris O'Brien Lifehouse
2065 - St Leonards - Northern Sydney Cancer Centre, Royal North Shore Hospital
2145 - Westmead - The Crown Princess Mary Cancer Centre - Westmead Hospital
2500 - Wollongong - Wollongong Hospital
2541 - Nowra - Shoalhaven District Memorial Hospital
ACTRN12621000586819
Radonc
Phase 2
Recruiting
A phase II study of platinum and etoposide chemotherapy, durvalumab with thoracic radiotherapy in the first line treatment of patients with extensive-stage small-cell lung cancer (
TROG-20.01-CHEST-RT
)
anti-PD-L1 monoclonal antibody
radiotherapy
topoisomerase inhibitor
Cancer
Lung cancer
Small-cell lung cancer
NSW
2145 - Westmead - The Crown Princess Mary Cancer Centre - Westmead Hospital
2148 - Blacktown - Blacktown Hospital, Blacktown Cancer and Haematology Centre
2170 - Liverpool - Liverpool Hospital
VIC
3066 - Epping - Northern Hospital
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre
QLD
4006 - Herston - The Royal Brisbane and Women's Hospital Cancer Centre
4102 - Woolloongabba - Princess Alexandra Hospital
ACTRN12612000274875
Advanced
Not Applicable
Not yet recruiting
Effects of alveolar recruitment during one-lung ventilation for lung cancer surgery on post-operative arterial oxygenation'
Lung cancer
ACTRN12611000520932
Advanced
Phase 1 / Phase 2
Recruiting
A Phase I/IIa trial of HA-Irinotecan, a formulation of hyaluronic acid and irinotecan, in the treatment of extensive stage small cell lung cancer and its effect on tumour stem cells. (
HA-Irinotecan-small-cell-lung-cancer-trial
)
hyaluronic acid
topoisomerase inhibitor
Small-cell lung cancer
NCT07353957
Advanced
Phase 2
Withdrawn
A Phase 2 Study to Investigate the Safety and Efficacy of Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer in Combination With Pembrolizumab as First-Line Treatment (
MCLA-158-CL04
)
anti-PD-1 monoclonal antibody
bispecific EGFR/LGR5 antibody
Lung cancer
VIC
3199 - Frankston - Peninsula Health Frankston Hospital
SA
5042 - Bedford Park - Flinders Medical Centre
Additional search terms:
API and Webpage URLs:
Copy /Bookmark
Filters
Recruitment Status
Recruiting (30)
Not yet recruiting (3)
Withdrawn (1)
Recruitment Country and State
NSW (22)
VIC (20)
QLD (10)
SA (10)
WA (7)
NZ (2)
ACT (1)
NT (1)
Phase
Phase 1 (6)
Phase 1 / Phase 2 (8)
Phase 2 (4)
Phase 2 / Phase 3 (1)
Phase 3 (10)
Trial Type
Advanced (29)
Radonc (5)
Cancer Therapy Class
PD-1/PD-L1
41%
PD-L1
32%
DLL3
24%
PD-1
15%
VEGFA
12%
B7H3
12%
VEGF
6%
Bcl2
3%
CTLA4
3%
PARG
3%
hGIIA-vimentin
3%
Trop2
3%
CDK2
3%
CDK4
3%
CDK6
3%
ER
3%
oestrogen axis
3%
fucosyl-GM1
3%
EGFR
3%
LGR5
3%
Facility
2145 - Westmead - The Crown Princess Mary Cancer Centre - Westmead Hospital (7)
2050 - Camperdown - Chris O'Brien Lifehouse (6)
5042 - Bedford Park - Flinders Medical Centre (5)
2298 - Waratah - Calvary Mater Newcastle Medical Oncology (4)
3168 - Clayton - Monash Medical Centre (4)
2065 - St Leonards - Northern Sydney Cancer Centre, Royal North Shore Hospital (4)
2170 - Liverpool - Liverpool Hospital (4)
3004 - Melbourne, Southbank - Alfred Health (4)
3350 - Ballarat - Grampians Health Service's Ballarat Base Hospital (3)
3021 - St Albans - Western Health - Sunshine Hospital (3)
4102 - Woolloongabba - Princess Alexandra Hospital (3)
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre (3)
4814 - Douglas - Townsville Cancer Centre - The Townsville Hospital (2)
5112 - Elizabeth Vale - Lyell McEwin Hospital (2)
3144 - Malvern - Cabrini Health, Cabrini Cancer Care Centre (2)
6009 - Nedlands - Linear Clinical Research (2)
4215 - Southport - Tasman Oncology (2)
3000 - Melbourne - Peter MacCallum Cancer Centre (2)
6150 - Murdoch - Fiona Stanley Hospital (2)
NZ.1023 - Grafton - Auckland City Hospital - Cancer & Blood Research (2)
2148 - Blacktown - Blacktown Hospital, Blacktown Cancer and Haematology Centre (2)
6008 - Subiaco - Bendat Family Comprehensive Cancer Centre - St John of God Subiaco Hospital (2)
2500 - Wollongong - Cancer Care Wollongong (2)
4006 - Herston - The Royal Brisbane and Women's Hospital Cancer Centre (2)
6009 - Nedlands - Sir Charles Gairdner Hospital - WA Cancer Centre (2)
3199 - Frankston - Peninsula Health Frankston Hospital (2)
2500 - Wollongong - Wollongong Hospital (2)
2605 - Garran - The Canberra Hospital (1)
3084 - Heidelberg - Warringal Private Hospital (1)
2031 - Randwick - Prince of Wales Hospital (1)
5000 - Adelaide - Royal Adelaide Hospital - Adelaide Cancer Centre (1)
NZ.3210 - Hamilton - Waikato Hospital (1)
4575 - Birtinya - Sunshine Coast University Hospital (1)
2217 - Kogarah - St George Private Hospital (1)
2228 - Miranda - Southside Cancer Care Centre (1)
3220 - Geelong - Andrew Love Cancer Centre, University Hospital Geelong (1)
3550 - Bendigo - Bendigo Health - Bendigo Cancer Centre (1)
3065 - Fitzroy - St Vincent's Hospital Melbourne (1)
4215 - Southport - Gold Coast University Hospital (1)
5000 - Adelaide - Cancer Research SA (1)
4870 - Cairns - Cairns Base Hospital (1)
5011 - Woodville South - The Queen Elizabeth Hospital (1)
5037 - Kurralta Park - Icon Cancer Centre Adelaide (1)
2560 - Campbelltown - Macarthur Cancer Therapy Centre - Campbelltown Hospital (1)
2747 - Kingswood - Nepean Hospital - Nepean Cancer Care Centre (1)
4120 - Greenslopes - Greenslopes Private Hospital (1)
2250 - Gosford - Central Coast Cancer Centre, Gosford Hospital (1)
2340 - Tamworth - Tamworth Hospital-North West Cancer Centre (1)
0870 - Alice Springs, Alice Springs Hospital (1)
2010 - Darlinghurst - St Vincent's Hospital Sydney - The Kinghorn Cancer Centre (1)
2541 - Nowra - Shoalhaven District Memorial Hospital (1)
3066 - Epping - Northern Hospital (1)
Cancer Type
Cancer
Lung cancer
Respiratory tract cancer
Solid tumour
Thoracic cancer
Carcinoma
Neuroendocrine carcinoma
Small-cell lung cancer
Small-cell neuroendocrine carcinoma
Breast cancer
Neuroendocrine tumour
Sarcoma
Gastrointestinal cancer
Gynaecological cancer
Male genital cancers
Ovarian cancer
Pancreatic cancer
Pancreatobiliary cancer
Prostate cancer
Upper gastrointestinal cancer
Urogenital cancer
Mesothelioma
Pleural mesothelioma
Sarcoma, synovial-like
Synovial sarcoma
Lung neuroendocrine tumour
Central nervous system cancer
Glioblastoma
Glioma
High-grade glioma
Malignant glioma
Neurological cancer
Skin cancer
Bladder cancer
Cervical cancer
Clear cell renal cell carcinoma
Colorectal cancer
Gastric cancer
Gastroesophageal cancer
HPV-related cancer
HPV16-positive cancer
Head and neck cancer
Hepatobiliary cancer
Hepatocellular carcinoma
Kidney cancer
Lower gastrointestinal cancer
Melanoma
Oesophageal cancer
Viral-related cancer
Haematological malignancy
Lymphoma
URLs for this search
API URL:
Copy
Bookmarkable URL:
Copy